{"filing":{"accession_number":"0001493152-26-032598","cik":"0001289340","ticker":"STXS","company_name":"Stereotaxis, Inc.","form":"8-K","filing_date":"2026-07-09","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1289340/000149315226032598/form8-k.htm"},"events":[{"id":17240,"run_id":15426,"accession_number":"0001493152-26-032598","anchor_item_number":"7.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"The filing discloses completion of Stereotaxis's acquisition of Robocath for approximately $20 million in cash and Common Stock, as stated in Item 8.01. This is a material acquisition event involving the combination of two robotic surgery companies with complementary technologies and strategic synergies, clearly meeting the definition of M\u0026A activity under Item 1.01/2.01 of the 8-K taxonomy.","company_name":"Stereotaxis, Inc.","ticker":"STXS","filing_date":"2026-07-09","form":"8-K","submitted_at":null,"items":[{"id":15612,"accession_number":"0001493152-26-032598","item_number":"7.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"The filing discloses completion of Stereotaxis's acquisition of Robocath for approximately $20 million in cash and Common Stock, as stated in Item 8.01. This is a material acquisition event involving the combination of two robotic surgery companies with complementary technologies and strategic synergies, clearly meeting the definition of M\u0026A activity under Item 1.01/2.01 of the 8-K taxonomy.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T13:06:30.539589+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":15612,"accession_number":"0001493152-26-032598","item_number":"7.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"The filing discloses completion of Stereotaxis's acquisition of Robocath for approximately $20 million in cash and Common Stock, as stated in Item 8.01. This is a material acquisition event involving the combination of two robotic surgery companies with complementary technologies and strategic synergies, clearly meeting the definition of M\u0026A activity under Item 1.01/2.01 of the 8-K taxonomy.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T13:06:30.539589+00:00","company_name":"Stereotaxis, Inc.","ticker":"STXS","filing_date":"2026-07-09"}]}